Medical News Daily
  • Providers
  • Health Tech
  • Marketing
  • Pharma
  • Regulatory
  • Special Reports
Subscribe

Regulatory

Recent Approval for Ublituximab

Recent Approval for Ublituximab

TG's first-in- class lymphoma med ukoniq was pulled from approval by the FDA last November, but now TG has won another approval. TG's anti-CD20 treatment, Briumvi, will be available beginning in the first quarter of 2023. TG Therapeutics Inc. Recently won approval for its ublituximab drug for people with relapsing
Pulse Health Jan 9, 2023
Proposed regulation intends to make it simpler for providers to care for substance users

Proposed regulation intends to make it simpler for providers to care for substance users

A proposed regulation intends to make it simpler for providers to coordinate care among clients suffering from substance usage condition (SUD) by balancing privacy defenses for those patients' medical records. The notification of proposed rulemaking, launched Monday by the Department of Health and Human Services (HHS), pursues a balance in
Pulse Health Dec 5, 2022
State attorneys general urge Apple to strengthen privacy protections for information about reproductive health.

State attorneys general urge Apple to strengthen privacy protections for information about reproductive health.

Attorneys General from ten states are urging Apple to enact more privacy safeguards for third-party apps that gather information on users' reproductive health. Following the Dobbs decision by the US Supreme Court overturning Roe v. Wade, a number of state attorneys general expressed privacy concerns in a letter (PDF) to
Pulse Health Nov 22, 2022

Subscribe to Medical News Daily

Don't miss out on the latest news. Sign up now to get access to the library of members-only articles.
  • Providers
  • Health Tech
  • Marketing
  • Pharma
  • Regulatory
  • Special Reports
Medical News Daily © 2023. Powered by Ghost